The Study About Glucose Lowering Effect of Vildagliptin in Type 2 Diabetes Patients Treated With Metformin and a Sulfonylurea.
Phase of Trial: Phase IV
Latest Information Update: 01 Jul 2015
At a glance
- Drugs Vildagliptin (Primary) ; Glimepiride; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms VISUAL
- 10 Jun 2017 Biomarkers information updated
- 27 May 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Mar 2014 Planned number of patients changed from 230 to 400, as per ClinicalTrials.gov record.